LY-02404

N/A

Report date: 2022/12/07 16:06:57

Base Information

Drug NameLY-02404
Drug Alias NameRed yeast rice extract（Luye Pharma）LY-02404
ClassificationNatural product/Extract > Plants extract
Mechanisms of ActionHMG-CoA reductase inhibitors
TargetsHMG-CoA reductase
Therapy Area/IndicationsDyslipidemiasPolycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLuye Pharma Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSichuan Provincial People'S HospitalLuye Pharma Group LtdLishui Hospital of TCM
Inactive CompaniesN/A
Active IndicationsDyslipidemiasPolycystic Ovary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A